In our study, the immunoreactivity of Twist (23.6% vs. 3.3%; p = 0.013) and EZH2 (25.6% vs. 8.2%; p = 0.037) was also significantly higher in lung adenocarcinoma than in epithelial cell of the normal lung. This evidence concerns the gene TWIST1 and lung adenocarcinoma.